Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Science (New York, N.Y.)
|
February 14, 2018
Programming gene and engineered-cell therapies with synthetic biology
Tasuku Kitada, Breanna DiAndreth, Brian Teague, et al.
Clinical Immunology (Orlando, Fla.)
|
May 13, 2022
The Tmod cellular logic gate as a solution for tumor-selective immunotherapy
Breanna DiAndreth, Agnes E Hamburger, Han Xu, et al.
Nature Communications
|
May 13, 2022
PERSIST platform provides programmable RNA regulation using CRISPR endoRNases
Breanna DiAndreth, Noreen Wauford, Eileen Hu, et al.
Frontiers in Immunology
|
April 1, 2022
Robust <i>In Vitro</i> Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell Therapy
Diane Manry, Kristian Bolanos, Breanna DiAndreth, et al.
Nucleic Acids Research
|
August 3, 2019
A 'poly-transfection' method for rapid, one-pot characterization and optimization of genetic systems
Jeremy J Gam, Breanna DiAndreth, Ross D Jones, et al.
Nature Communications
|
November 11, 2020
An endoribonuclease-based feedforward controller for decoupling resource-limited genetic modules in mammalian cells
Ross D Jones, Yili Qian, Velia Siciliano, et al.
Nature Communications
|
May 16, 2018
Engineering modular intracellular protein sensor-actuator devices
Velia Siciliano, Breanna DiAndreth, Blandine Monel, et al.
Molecular Immunology
|
October 5, 2020
Engineered T cells directed at tumors with defined allelic loss
Agnes E Hamburger, Breanna DiAndreth, Jiajia Cui, et al.
Journal for Immunotherapy of Cancer
|
January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
Talar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Frontiers in Immunology
|
February 12, 2024
Geometric parameters that affect the behavior of logic-gated CAR T cells
Alexander C Partin, Richele Bruno, Sanam Shafaattalab, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Science (New York, N.Y.)
|
February 14, 2018
Programming gene and engineered-cell therapies with synthetic biology
Tasuku Kitada, Breanna DiAndreth, Brian Teague, et al.
Clinical Immunology (Orlando, Fla.)
|
May 13, 2022
The Tmod cellular logic gate as a solution for tumor-selective immunotherapy
Breanna DiAndreth, Agnes E Hamburger, Han Xu, et al.
Nature Communications
|
May 13, 2022
PERSIST platform provides programmable RNA regulation using CRISPR endoRNases
Breanna DiAndreth, Noreen Wauford, Eileen Hu, et al.
Frontiers in Immunology
|
April 1, 2022
Robust <i>In Vitro</i> Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell Therapy
Diane Manry, Kristian Bolanos, Breanna DiAndreth, et al.
Nucleic Acids Research
|
August 3, 2019
A 'poly-transfection' method for rapid, one-pot characterization and optimization of genetic systems
Jeremy J Gam, Breanna DiAndreth, Ross D Jones, et al.
Nature Communications
|
November 11, 2020
An endoribonuclease-based feedforward controller for decoupling resource-limited genetic modules in mammalian cells
Ross D Jones, Yili Qian, Velia Siciliano, et al.
Nature Communications
|
May 16, 2018
Engineering modular intracellular protein sensor-actuator devices
Velia Siciliano, Breanna DiAndreth, Blandine Monel, et al.
Molecular Immunology
|
October 5, 2020
Engineered T cells directed at tumors with defined allelic loss
Agnes E Hamburger, Breanna DiAndreth, Jiajia Cui, et al.
Journal for Immunotherapy of Cancer
|
January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
Talar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Frontiers in Immunology
|
February 12, 2024
Geometric parameters that affect the behavior of logic-gated CAR T cells
Alexander C Partin, Richele Bruno, Sanam Shafaattalab, et al.
Page
of 2